Balkrishan Kalra

President, Chief Executive Officer, and Director at Genpact

Board

Since February 9, 2024

Age

55 years

Tenure

Joined Genpact in 1999 and rose through several roles—including Senior Vice President, Business Leader for Consumer Goods, Retail, and Life Sciences (2008-February 2024), as well as leading the Healthcare (since 2016) and Financial Services (since 2020) businesses—culminating in being appointed President, Chief Executive Officer, and Director on February 9, 2024.

Also at Genpact

Anil Nanduru

Senior Vice President and Global Business Leader for High Tech & Manufacturing and Consumer & Healthcare

Heather White

Senior Vice President, Chief Legal Officer, and Corporate Secretary

Michael Weiner

Senior Vice President and Chief Financial Officer

About

Balkrishan Kalra is 55 years old as of March 2025, showcasing a seasoned professional with a long-standing commitment to Genpact.

He embarked on his journey with Genpact in 1999, taking on a series of progressively responsible roles that laid the foundation for his deep industry expertise and leadership skills.

Throughout his career, he held key responsibilities such as serving as the Senior Vice President and Business Leader for the Consumer Goods, Retail, and Life Sciences sectors from 2008 until February 2024, while also steering the Healthcare business from 2016 and the Financial Services business since 2020, which highlights his diverse managerial experience.

In a significant leadership milestone, he was appointed as President, Chief Executive Officer, and Director on February 9, 2024, marking a pivotal moment in his career at Genpact, where his vision and innovative approach have been instrumental in driving progress.

$G Performance Under Balkrishan Kalra

Past Roles

Organization	Role	Date Range
Genpact	Senior Vice President and Business Leader for Financial Services	2020 - February 2024
Genpact	Senior Vice President and Business Leader for Healthcare	2016 - February 2024
Genpact	Senior Vice President and Business Leader for Consumer Goods, Retail and Life Sciences	2008 - February 2024

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$750,000	2023 Annual	Paid as part of the regular salary package
All Other Compensation	$22,384	2023	Other fixed compensation not tied to performance
Deferred Compensation Executive Contributions	$694,475	2023	Contributions to the deferred compensation plan
Involuntary Termination Potential Payments	$4,867,747	Contingent upon involuntary termination	Includes Cash Severance ($1,298,077), Equity Treatment ($3,533,351), and Health and Welfare ($36,319)
Change of Control Potential Payment	Either $3,469,459 or $6,855,265	Contingent upon change of control event	Depends on whether the award is accelerated or assumed/substituted/continued by the acquiring entity
Termination Due to Death or Disability Potential Payment	$702,484	Upon termination due to death or disability	Provided as an equity treatment payment

Performance Compensation

Data from FY 2023

Stock Awards (Equity Incentive Plan Awards)

Metric (Unit & Scale)	Value (2023)
Grant Date [date]	March 15, 2023
Grant Date Fair Value (USD)	$4,704,396
Performance Period	Jan 1, 2023 - Dec 31, 2025
Adjusted EPS Threshold (%)	97%
Adjusted EPS Target (%)	100%
Adjusted EPS Outstanding (%)	103%
Revenue Threshold (%)	97%
Revenue Target (%)	100%
Revenue Outstanding (%)	102%
PSU Target Shares	44,927
PSU Maximum Shares	107,824
RSU Shares Granted	15,791
TSR Modifier Range	0.8x to 1.2x

Non-Equity Incentive Plan Compensation

Metric (Unit & Scale)	Value (2023)
Grant Date [date]	March 15, 2023
Grant Date Fair Value (USD)	$505,122
Target Bonus (USD)	$750,000
Threshold Bonus (USD)	$210,938
Maximum Bonus (USD)	$2,250,000
Actual Bonus Payment Multiplier (%)	92%
Vesting Schedule	No vesting; paid at fiscal year-end
Performance Metrics - Financial	Business unit revenue, net bookings, renewal bookings, qualified inflows, AOI margin, gross profit margin
Performance Metrics - Non-Financial	Driving client success, technology-first approach, strengthening leadership, DEI, M&A strategy